Back to Authors

Mielke, Michelle M.

https://orcid.org/0000-0001-7177-1185

A5090710393 | I4405269449

Mayo Clinic

Wake Forest University Health Sciences

Citations 530

O3‐10‐03: SEX AND APOE EFFECTS ON MEMORY PERFORMANCE, NEURODEGENERATION, AND B‐AMYLOID ACROSS THE ADULT LIFESPAN

Alzheimer's & Dementia | September 6, 2014 | Volume: 10 | Issue: 4S_Part_3 | Pages: No page available

10.1016/j.jalz.2014.04.325

Association of Lifetime Intellectual Enrichment With Cognitive Decline in the Older Population

JAMA Neurology | June 23, 2014 | Volume: 71 | Issue: 8 | Pages: 1017

10.1001/jamaneurol.2014.963 | PMID 25054282

A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease

Alzheimer's & Dementia | May 3, 2014 | Volume: 10 | Issue: 6 | Pages: 844-852

10.1016/j.jalz.2014.01.001 | PMID 24798886

Abstract There is increasing evidence that subjective cognitive decline (SCD) in individuals with unimpaired performance on cognitive tests may represent the first symptomatic manifestation of Alzheimer's disease (AD). The research on SCD in early AD, however, is limited by the absence of common standards. The working group of the Subjective Cognitive Decline Initiative (SCD‐I) addressed this deficiency by reaching consensus on terminology and on a conceptual framework for research on SCD in AD. In this publication, research criteria for SCD in pre‐mild cognitive impairment (MCI) are presented. In addition, a list of core features proposed for reporting in SCD studies is provided, which will enable comparability of research across different settings. Finally, a set of features is presented, which in accordance with current knowledge, increases the likelihood of the presence of preclinical AD in individuals with SCD. This list is referred to as SCD plus .
Progranulin protein levels are differently regulated in plasma and CSF

Neurology | April 25, 2014 | Volume: 82 | Issue: 21 | Pages: 1871-1878

10.1212/wnl.0000000000000445 | PMID 24771538

Rates of β-amyloid accumulation are independent of hippocampal neurodegeneration

Neurology | April 5, 2014 | Volume: 82 | Issue: 18 | Pages: 1605-1612

10.1212/wnl.0000000000000386 | PMID 24706010

Baseline Neuropsychiatric Symptoms and the Risk of Incident Mild Cognitive Impairment: A Population-Based Study

American Journal of Psychiatry | April 4, 2014 | Volume: 171 | Issue: 5 | Pages: 572-581

10.1176/appi.ajp.2014.13060821 | PMID 24700290

Association of type 2 diabetes with brain atrophy and cognitive impairment

Neurology | March 20, 2014 | Volume: 82 | Issue: 13 | Pages: 1132-1141

10.1212/wnl.0000000000000269 | PMID 24647028

A Prospective Study of Chronic Obstructive Pulmonary Disease and the Risk for Mild Cognitive Impairment

JAMA Neurology | March 17, 2014 | Volume: 71 | Issue: 5 | Pages: 581

10.1001/jamaneurol.2014.94 | PMID 24637951

A 'bird's Eye' View on the Current Status and Potential Benefits of Blood Biomarkers for Parkinson's Disease

Biomarkers in Medicine | February 12, 2014 | Volume: 8 | Issue: 2 | Pages: 225-227

10.2217/bmm.13.139 | PMID 24521018

Head trauma and in vivo measures of amyloid and neurodegeneration in a population-based study

Neurology | December 27, 2013 | Volume: 82 | Issue: 1 | Pages: 70-76

10.1212/01.wnl.0000438229.56094.54 | PMID 24371306